Upstream Bio, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Upstream Bio, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 9, 2026.
NASDAQ
Upstream Bio, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Upstream Bio, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 10, 2025, to elect directors and ratify the appointment of its independent accounting firm.